A phase II study of single agent OSI-7904L in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Hough, B.
Posner, M.
Chung, C.
Hainsworth, J.
Horan, J.
Chick, J.
Gibson, M. K.
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] OSI Pharmaceut, Oxford, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17005
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC)
    Tang, Patricia
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Colevas, A. Dimitrios
    Johnson, Caitlin
    Pond, Greg R.
    Winquist, Eric
    ANNALS OF ONCOLOGY, 2006, 17 : 186 - 186
  • [22] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    CANCER, 2001, 91 (07) : 1316 - 1323
  • [23] Phase II trial of irinotecan (Ir) plus cisplatin (CDDP) in patients with recurrent or metastatic squamous carcinoma of the head and neck (SCCHN)
    Gilbert, J.
    Cmelak, A.
    Burkey, B.
    Sinard, R.
    Yarborough, W.
    Netterville, J.
    Paty, V.
    Chung, C.
    Hudson, T.
    Murphy, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Tanguy Seiwert
    John Sarantopoulos
    Howard Kallender
    Stewart McCallum
    Harold N. Keer
    George Blumenschein
    Investigational New Drugs, 2013, 31 : 417 - 424
  • [25] Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Seiwert, Tanguy
    Sarantopoulos, John
    Kallender, Howard
    McCallum, Stewart
    Keer, Harold N.
    Blumenschein, George, Jr.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (02) : 417 - 424
  • [26] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    Couteau, C
    Chouaki, N
    Leyvraz, S
    Oulid-Aissa, D
    Lebecq, A
    Domenge, C
    Groult, V
    Bordessoule, S
    Janot, F
    De Forni, M
    Armand, JP
    BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 457 - 462
  • [27] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    C Couteau
    N Chouaki
    S Leyvraz
    D Oulid-Aissa
    A Lebecq
    C Domenge
    V Groult
    S Bordessoule
    F Janot
    M De Forni
    J-P Armand
    British Journal of Cancer, 1999, 81 : 457 - 462
  • [28] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma
    Elser, Christine
    Siu, Lillian L.
    Winquist, Eric
    Agulnik, Mark
    Pond, Gregory R.
    Chin, Soo F.
    Francis, Peggy
    Cheiken, Robin
    Elting, James
    McNabola, Angela
    Wilkie, Dean
    Petrenciuc, Oana
    Chen, Eric X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773
  • [29] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Espinosa, E
    Zamora, P
    Millá, A
    Morales, S
    Molina, R
    Mira, M
    Barón, MG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059
  • [30] Final results of a phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).
    Blumenschein, George R.
    Glisson, Bonnie S.
    Lu, Charles
    Sabichi, Anita Lyn
    Ginsberg, Lawrence E.
    Bartos, Claudia I.
    Feng, Lei
    Tran, Hai T.
    El-Naggar, Adel K.
    Lippman, Scott Michael
    Kies, Merrill S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345